<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mig, the monokine induced by interferon-gamma, is a CXC chemokine active as a chemoattractant for activated T cells </plain></SENT>
<SENT sid="1" pm="."><plain>Mig is related functionally to interferon-inducible protein 10 (IP-10), with which it shares a receptor, CXCR3 </plain></SENT>
<SENT sid="2" pm="."><plain>Previously, IP-10 was found to have antitumor activity in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, murine Mig <z:chebi fb="40" ids="33697">RNA</z:chebi> was found to be expressed at higher levels in regressing Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> established in <z:mp ids='MP_0003815'>nude</z:mp> mice compared with progressively growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Daily inoculations of purified recombinant human Mig into <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumors</z:e> growing subcutaneously in <z:mp ids='MP_0003815'>nude</z:mp> mice consistently caused <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> associated with extensive vascular damage </plain></SENT>
<SENT sid="5" pm="."><plain>These effects were indistinguishable from those produced by intratumor inoculations of <z:e sem="disease" ids="C0006413" disease_type="Neoplastic Process" abbrv="BL">Burkitt's tumors</z:e> with IP-10 </plain></SENT>
<SENT sid="6" pm="."><plain>These results support the notion that Mig, like IP-10, has antitumor activity in vivo </plain></SENT>
</text></document>